share_log

Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24

Goldman Sachs Initiates Coverage On Olema Pharmaceuticals With Buy Rating, Announces Price Target of $24

高盛以买入评级启动对Olema Pharmicals的报道,宣布目标股价为24美元
Moomoo 24/7 ·  04/02 07:09

Goldman Sachs analyst Richard Law initiates coverage on Olema Pharmaceuticals (NASDAQ:OLMA) with a Buy rating and announces Price Target of $24.

高盛分析师理查德·劳以买入评级启动了对奥莱玛制药(纳斯达克股票代码:OLMA)的报道,并宣布目标股价为24美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发